- By Jackie Connor
- Posted November 16, 2016
Quality Genetic Testing and Why it Matters on Lifetime's 'Access Health' Television
Genetic testing has become an impactful method for clinicians to help their patients confirm their chances of inheriting a genetic disease. Testing quality is an imperative element in determining a patient’s next steps and whether their family members should also be tested. On November 16th, Ambry CEO Aaron Elliott, PhD and Robina Smith, MD,…
- By Jackie Connor
- Posted November 7, 2016
Ambry Execs Discuss the Importance of Genetic Testing on Lifetime's "Access Health" Program
Genetic testing has helped research for breast cancer progress immeasurably, and thanks to some high profile cases, more women are opting for genetic testing when they go in for mammograms and other checkups. As a result, more companies are offering a variety of genetic tests geared towards detecting mutations in the BRCA1 and BRCA2…
- By Jackie Connor
- Posted October 26, 2016
Research Shows BRCA2 may be Linked to Brain Tumors
In 2016, it is estimated that 246,660 new cases of breast cancer will be diagnosed in women and 2,600 cases in men and out of those cases, only about 5-10% will be hereditary. The most common cause for hereditary breast cancer cases are due to mutations in the BRCA1 and BRCA2 genes. Thanks to recent research at Ambry, it is now…
- By Jackie Connor
- Posted October 20, 2016
Ambry Supports Breast Cancer Awareness Month throughout October
In honor of Breast Cancer Awareness month, Ambry is proud to support many non-profit foundations and organizations, including the Mauli Ola Foundation’s 3rd annual Battle for the Breasts (B4TB). The B4TB is an online surf contest featuring 16 professional women surfers who are each paired with cancer clinics and/or foundations. Each surfer…